5-氟-异喹啉 | 394-66-1

• 物质功能分类: 医药中间体 - 异喹啉类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 中文名称: 5-氟-异喹啉
• 中文别名: 5-氟异喹啉
• 英文名称: 5-fluoroisoquinoline
• 英文别名: 5-Fluor-isochinolin
• CAS: 394-66-1
• 化学式: C₉H₆FN
• mdl: MFCD05982026
• 分子量: 147.152
• InChiKey: YZPWGDDACXZRFI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2933499090

反应信息

• 作为产物：
  描述：

  5-羟基异喹啉 在 PhenoFluor 作用下， 以 甲苯 为溶剂， 反应 24.0h， 以81%的产率得到5-氟-异喹啉
  参考文献：
  名称：

  PhenoFluorMix: Practical Chemoselective Deoxyfluorination of Phenols

  摘要：

  A practical deoxyfluorination with novel deoxyfluorinating reagent PhenoFluorMix, a mixture of N,N'-1,3-bis(2,6-diisopropylphenyl)chloroimidazolium chloride and CsF, is presented. PhenoFluorMix overcomes the challenges associated with hydrolysis of PhenoFluor. PhenoFluorMix does not hydrolyze, is readily available on decagram scale, and is storable in air. In this paper, we demonstrate the practicality of the reagent and exhibit the deoxyfluorination of a variety of phenols and heterocycles.

  DOI：

  10.1021/ol5035518

文献信息

• Novel substituted heteroaryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors
  申请人：Eriksen Birgitte L.

  公开号：US20090023772A1

  公开（公告）日：2009-01-22

  This invention relates to novel substituted heteroaryloxy alkylamines useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.

  这项发明涉及一种新型的取代杂环氧烷胺基烷胺，可用作单胺神经递质再摄取抑制剂。在其他方面，该发明涉及将这些化合物用于治疗方法以及包含该发明化合物的药物组合物。
• [EN] NOVEL SUBSTITUTED HETEROARYLOXY ALKYLAMINES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS<br/>[FR] NOUVELLES HETEROARYLOXYALKYLAMINES SUBSTITUEES ET LEUR UTILISATION COMME INHIBITEURS DE RECAPTAGE DU NEUROTRANSMETTEUR MONOAMINE
  申请人：NEUROSEARCH AS

  公开号：WO2006021565A1

  公开（公告）日：2006-03-02

  This invention relates to novel substituted heteroaryloxy alkylamines of structure (I) useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.

  这项发明涉及一种新型的取代杂环氧基烷胺，其结构为(I)，可用作单胺神经递质再摄取抑制剂。在其他方面，该发明涉及将这些化合物用于治疗方法以及包含该发明化合物的药物组合物。
• LUMINESCENCE DEVICE AND DISPLAY APPARATUS
  申请人：Kamatani Jun

  公开号：US20070212570A1

  公开（公告）日：2007-09-13

  A metal coordination compound having the following structure: wherein M′ is Ir or Rh, m′ is 2, and are identical to each other and are represented by a substituted or unsubstituted phenyl isoquinoline ligand. A luminescence device and a display apparatus using this metal coordination is compound are provided.

  一种具有以下结构的金属配位化合物：其中M'为Ir或Rh，m'为2，R1，R2和R3相同且由替代或未替代的苯基异喹啉配体表示。提供了使用此金属配位化合物的发光装置和显示装置。
• DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE
  申请人：Aerie Pharmaceuticals, Inc.

  公开号：EP3828172A1

  公开（公告）日：2021-06-02

  Compounds that are inhibitors of both rho kinase and of a monoamine transporter (MAT) acting to improve the disease state or condition. Further provided are compositions comprising the compounds. Further provided are methods for treating diseases or conditions, the methods comprising administering compounds according to the invention. One such disease may be glaucoma for which, among other beneficial effects, a marked reduction in intraocular pressure (IOP) may be achieved.

  既是 rho 激酶抑制剂又是单胺转运体 (MAT) 抑制剂的化合物，其作用是改善疾病状态或状况。还提供了包含这些化合物的组合物。进一步提供了治疗疾病或病症的方法，这些方法包括施用根据本发明的化合物。其中一种疾病可能是青光眼，除其他有益效果外，可显著降低眼内压（IOP）。
• 3-ARYLOXY-3-ARYL-PROPYLAMINE COMPOUND AND USES THEREOF
  申请人：Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd

  公开号：EP3838900A1

  公开（公告）日：2021-06-23

  A 3-aryloxy-3-aryl-propylamine compound or a pharmaceutically acceptable salt of same, or a prodrug of same, and uses thereof. The compound has the structure of formula I. The compound, the pharmaceutically acceptable salt of same, or the prodrug of same provides an inhibitory effect with respect to a transient receptor potential (TRP) channel protein, and provides great therapeutic effects with respect to diseases related to the transient receptor potential channel protein.

  一种 3-芳氧基-3-芳基-丙胺化合物或其药学上可接受的盐或其原药及其用途。该化合物具有式 I 的结构。该化合物、其药学上可接受的盐或其原药对瞬时受体电位（TRP）通道蛋白有抑制作用，对与瞬时受体电位通道蛋白有关的疾病有很好的治疗效果。